Fortune 500 Sales Intelligence Blog

Johnson & Johnson (NYSE: JNJ) is ranked #35 on the 2020 Fortune 500 list. They are in talks to supply Covid-19 vaccine in Europe. J&J postponed 2020 Medical Devices Business Review due to Coronavirus. They are expanding their partnership with the U.S. Department of Health & Human Services to accelerate research. Jim Swanson is the new EVP and CIO as of 10 months ago.